Published by Conor Coyle on 6th March 2017
(ShareCast News) - US healthcare firm Concert Pharmaceuticals' share price shot up more than 80% on Monday after the company announced a deal to sell its cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals for $250m.
URL: http://www.digitallook.com/dl/news/story/25637484/...